Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target?

Volume:8   Issue:7
Pp: 545-553
Thomas Arnesen, Paul R. Thompson, Jan Erik Varhaug and Johan R. Lillehaug
DOI: 10.2174/156800908786241113

Cell-Specific Induction of Apoptosis by Rationally Designed Bivalent Aptamer-siRNA Transcripts Silencing Eukaryotic Elongation Factor 2

Volume:8   Issue:7
Pp: 554-565
Ulrich Wullner, Inga Neef, Andreas Eller, Michael Kleines, Mehmet Kemal Tur and Stefan Barth
DOI: 10.2174/156800908786241078

Notch Signaling: A Potential Therapeutic Target in Prostate Cancer

Volume:8   Issue:7
Pp: 566-580
M. A. Villaronga, C. L. Bevan and B. Belandia
DOI: 10.2174/156800908786241096

Interaction Between Estrogen Receptor Alpha and Insulin/IGF Signaling in Breast Cancer

Volume:8   Issue:7
Pp: 597-610
Marilena Lanzino, Catia Morelli, Cecilia Garofalo, Maria Luisa Panno, Loredana Mauro, Sebastiano Ando and Diego Sisci
DOI: 10.2174/156800908786241104

Obesity-Enhanced Colon Cancer: Functional Food Compounds and their Mechanisms of Action

Volume:8   Issue:7
Pp: 611-633
Jairam Vanamala, Christopher C. Tarver and Peter S. Murano
DOI: 10.2174/156800908786241087

Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

Volume:8   Issue:7
Pp: 634-646
Yong Lin, Ranxin Shi, Xia Wang and Han-Ming Shen
DOI: 10.2174/156800908786241050